Comments on "Chromogranin A in the Follow-up of Gastroenteropancreatic Neuroendocrine Neoplasms Is It Really Game Over? A Systematic Review and Meta-analysis"

被引:0
|
作者
Zhang, Kai [1 ]
Tang, Qilin [2 ]
机构
[1] Tianjin Gong An Hosp, Dept Acupuncture & Moxibust, Tianjin, Peoples R China
[2] Hebei Univ Chinese Med, Sch Basic Med Sci, Shijiazhuang, Hebei, Peoples R China
关键词
D O I
10.1097/MPA.0000000000001638
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:E80 / E81
页数:2
相关论文
共 50 条
  • [1] Comments on "Chromogranin A in the Follow-up of Gastroenteropancreatic Neuroendocrine Neoplasms Is It Really Game Over? A Systematic Review and Meta-analysis" Reply
    Rossi, Roberta Elisa
    Massironi, Sara
    PANCREAS, 2020, 49 (09) : E81 - E82
  • [2] Chromogranin A in the Follow-up of Gastroenteropancreatic Neuroendocrine Neoplasms: Is It Really Game Over? A Systematic Review and Meta-analysis
    Rossi, Roberta Elisa
    Ciafardini, Clorinda
    Sciola, Valentina
    Conte, Dario
    Massironi, Sara
    PANCREAS, 2018, 47 (10) : 1249 - 1255
  • [3] Follow-Up in Neuroendocrine Neoplasms: Can Chromogranin A Be the Cofounder?
    Martins, D.
    Batista, C.
    Velez, A.
    Macario, F.
    Carrilho, F.
    NEUROENDOCRINOLOGY, 2017, 105 : 310 - 310
  • [4] Prognostic factors for relapse in resected gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis
    Broadbent, Rachel
    Wheatley, Roseanna
    Stajer, Sabrina
    Jacobs, Timothy
    Lamarca, Angela
    Hubner, Richard A.
    Valle, Juan W.
    Amir, Eitan
    McNamara, Mairead G.
    CANCER TREATMENT REVIEWS, 2021, 101
  • [5] Efficacy and safety of neoadjuvant therapy in gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis
    Yan, Yu
    Wu, Danzhu
    Wang, Weizhen
    Lv, Yajuan
    Yang, Liyuan
    Liu, Yinglong
    Dong, Peng
    Yu, Xinshuang
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (02) : 633 - 641
  • [6] Prognostic factors for relapse in resected gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis
    Broadbent, R.
    Wheatley, R.
    Stajer, S.
    Jacobs, T.
    Lamarca, A.
    Hubner, R.
    Valle, J.
    Amir, E.
    McNamara, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S114 - S114
  • [7] Chromogranin A in the Follow-Up of Digestive Neuroendocrine Neoplasms: Is It a Useful Biomarker?
    Merola, E.
    Fave, Delle G.
    Blankenstein, O.
    Wiedenmann, B.
    Pavel, M.
    NEUROENDOCRINOLOGY, 2016, 103 : 49 - 49
  • [8] Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-analysis
    Ziogas, Ioannis A.
    Tasoudis, Panagiotis T.
    Borbon, Luis C.
    Sherman, Scott K.
    Breheny, Patrick J.
    Chandrasekharan, Chandrikha
    Dillon, Joseph S.
    Bellizzi, Andrew M.
    Howe, James R.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (01) : 148 - 160
  • [9] SERUM CHROMOGRANIN-A IN THE DIAGNOSIS AND FOLLOW-UP OF NEUROENDOCRINE TUMORS OF THE GASTROENTEROPANCREATIC TRACT
    SCHURMANN, G
    RAETH, U
    WIEDENMANN, B
    BUHR, H
    HERFARTH, C
    WORLD JOURNAL OF SURGERY, 1992, 16 (04) : 697 - 702
  • [10] Chromogranin A as a Marker in the Follow-up of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs). A Systematic Review
    Rossi, R. E.
    Ciafardini, C.
    Conte, D.
    Sciola, V
    Massironi, S.
    NEUROENDOCRINOLOGY, 2018, 106 : 163 - 163